Evidence map›Paper›PMID 31420909›Full record

ArticleJournal of thrombosis and haemostasis : JTH2019

Polyphosphate, Zn

Yuqi Wang, Ivan Ivanov, Stephanie A Smith, David Gailani, James H Morrissey

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Crystal structure of coagulation factor XII N-terminal domains 1-5.Acta crystallographica. Section D, Structural biology · 2025
    Article
  5. Article
  6. Article
  7. Factor XII Structure-Function Relationships.Seminars in thrombosis and hemostasis · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Effects of Polyphosphate on Leukocyte Function.Progress in molecular and subcellular biology · 2022
    Review
  12. Article
  13. Article
  14. Proteolytic activity of contact factor zymogens.Journal of thrombosis and haemostasis : JTH · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yuqi WangDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA.
Ivan IvanovDepartment of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Stephanie A SmithDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0003-4895-6215
David GailaniDepartment of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
James H MorrisseyDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0002-1570-1569
University of Michigan · USVanderbilt University Medical Center · US

Funding

Analysis and Characterization of Trauma-Induced CoagulopathyUM1HL120877 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MORRISSEY, JAMES H., WISNIEWSKI, STEPHEN R · 2013 to 2019
$26.6M
Physiology and Molecular Biology of Factor XIR01HL058837 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAILANI, DAVID · 1997 to 2017
$6.4M
Biochemistry and Pathophysiology of Factor XI and Contact ActivationR35HL140025 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAILANI, DAVID · 2018 to 2024
$5.5M
Mechanisms in Blood ClottingR35HL135823 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORRISSEY, JAMES H. · 2017 to 2023
$4.8M
Factor Xl in Vascular ThrombosisR01HL081326 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAILANI, DAVID · 2007 to 2017
$3.5M
NHLBI NIH HHS R01 HL058837NHLBI NIH HHS R01 HL081326NHLBI NIH HHS R35 HL135823NHLBI NIH HHS R35 HL140025NHLBI NIH HHS UM1 HL120877
6 · The paper itself

Abstract

backgroundInorganic polyphosphate modulates the contact pathway of blood clotting, which is implicated in thrombosis and inflammation. Polyphosphate polymer lengths are highly variable, with shorter polymers (approximately 60-100 phosphates) secreted from human platelets, and longer polymers (up to thousands of phosphates) in microbes. We previously reported that optimal triggering of clotting via the contact pathway requires very long polyphosphates, although the impact of shorter polyphosphate polymers on individual proteolytic reactions of the contact pathway was not interrogated. OBJECTIVES AND

methodsWe conducted in vitro measurements of enzyme kinetics to investigate the ability of varying polyphosphate sizes, together with high molecular weight kininogen and Zn

resultsThe individual contact pathway reactions were differentially dependent on polyphosphate length. Very long-chain polyphosphate was required to support factor XII autoactivation, whereas platelet-size polyphosphate significantly accelerated the activation of factor XII by kallikrein, and the activation of prekallikrein by factor XIIa. Intriguingly, polyphosphate did not support prekallikrein autoactivation. We also report that high molecular weight kininogen was required only when kallikrein was the enzyme (ie, FXII activation by kallikrein), whereas Zn

conclusionsPlatelet polyphosphate and Zn

Indexed as

Blood CoagulationEnzyme ActivationFactor XaHumansKineticsKininogen, High-Molecular-WeightMolecular WeightPolyphosphatesProteolysisZincFactor XaKininogen, High-Molecular-WeightPolyphosphatesZincblood coagulation factorspolyphosphatesprekallikreinthrombosiszinc

Identifiers

PMID31420909
PMCPMC6893101
OpenAlexW2968890440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.